CA Patent

CA2806973A1 — Preservative free bimatoprost solutions

Assigned to Allergan Inc · Expires 2012-02-02 · 14y expired

What this patent protects

The present invention is directed to preservative-free solutions of bimatoprost for lowering intra-ocular pressure and treatment of glaucoma.

USPTO Abstract

The present invention is directed to preservative-free solutions of bimatoprost for lowering intra-ocular pressure and treatment of glaucoma.

Drugs covered by this patent

Lumigan (BIMATOPROST)

Patent Metadata

Patent number: CA2806973A1
Jurisdiction: CA
Classification: —
Expires: 2012-02-02
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.